PBAC Public Summary Documents - March 2012

Public summary documents relating to the March 2012 PBAC meeting

• Abiraterone, tablet, 250 mg (as acetate), Zytiga® - March 2012
• Aflibercept, solution for intravitreal injection, 40 mg per mL, Eylea® - March 2012
• Agomelatine, tablet, 25mg, Valdoxan® - March 2012
• Boceprevir, capsule, 200 mg, Victrelis® - March 2012
• Bortezomib, powder for injection 1 mg (solvent required), Velcade® - March 2012
• Dapagliflozin, tablet, 10 mg, (as propanediol monohydrate), Forxiga® (dual oral) - March 2012
• Dapagliflozin, tablet, 10 mg, (as propanediol monohydrate), Forxiga® (insulin) - March 2012
• Denosumab, injection 60 mg in 1 mL pre-filled syringe, Prolia® - March 2012
• Etanercept, injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL; injections 50 mg in 1 mL single use pre-filled syringes; injection 50 mg in 1 mL single use auto-injector, Enbrel® - March 2012
• Ezetimibe with simvastatin, tablet, 10 mg-20 mg, Vytorin®- March 2012
• Human Menopuasal Gonadotrophin, powder for injection, 600 IU and 1200 IU with solvent, Menopur® - March 2012
• Imatinib, tablets, 100 mg and 400 mg (as mesylate), Glivec® - March 2012
• Ipilimumab, concentrate solution for I.V. infusion, 50 mg in 10 mL, 200 mg in 40 mL, Yervoy® - March 2012
• Naproxen and esomeprazole, tablet, 500 mg-20 mg (as magnesium trihydrate), Vimovo® - March 2012
• Pazopanib, tablet, 200 mg and 400 mg (as hydrochloride), Votrient® - March 2012
• Pregabalin, capsules, 25 mg, 75 mg, 150 mg and 300 mg, Lyrica® - March 2012
• Rasagiline, tablet, 1 mg (as mesilate), Azilect® - March 2012
• Rivaroxaban, tablet, 15 mg and 20 mg, Xarelto® - March 2012
• Rivaroxaban (AF), tablet, 15 mg and 20 mg, Xarelto® - March 2012
• Sunitinib malate, capsule, 12.5 mg, 25 mg and 50 mg (base), Sutent® - March 2012
• Tafluprost, eye drops, 15 micrograms per mL (0.0015%), single dose units, 0.3 mL, 30, Saflutan® - March 2012
• Taliglucerase Alfa, powder for I.V. infusion, 200 units, Elelyso® - March 2012
• Tapentadol, tablet, 50 mg, 100 mg, 150 mg, 200 mg and 250 mg (as hydrochloride) (sustained release), Palexia SR® - March 2012
• Telaprevir, tablet, 375 mg, Incivo® - March 2012
• Velaglucerase alfa, powder for IV infusion, 400 units in 4 mL, VPRIV® - March 2012